Precision for Medicine
↗Bethesda, Maryland, USA
Precision for Medicine is a specialized Contract Research Organization (CRO) and the first to be built specifically for the era of precision medicine. The company integrates clinical trial execution with advanced biomarker research, specialty lab services, and data science to accelerate the development of life-changing therapies. They focus heavily on oncology, rare diseases, and cell and gene therapy.
As a subsidiary of Precision Medicine Group, the company provides a comprehensive suite of services including global clinical trial management, regulatory consulting, and health economics. They are known for their 'Precision Advantage' approach, which uses patient-specific data and biomarkers to optimize trial design and patient recruitment.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$1B
Founded:2012
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$2000M
Investors:Blackstone, TPG, Berkshire Partners, Vida Ventures, Oak HC/FT
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Cell therapy, Gene therapy, mRNA, Antibody-Drug Conjugates (ADCs)
Active Trials:450
Trial Phases:Phase 1: 150 | Phase 2: 200 | Phase 3: 80 | Phase 4: 20
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Precision Medicine Group
Subsidiaries:Project Farma, Simbec-Orion, ACT121, BioScience Communications
Key Partnerships:Multiple Top 10 Pharma companies, Illumina (Genomic testing collaboration), Various academic medical centers for trial sites
COMPETITION
Position:Leader
Competitors:IQVIA, PPD (Thermo Fisher Scientific), ICON plc, Labcorp Drug Development, Medpace, Parexel
LEADERSHIP
Key Executives:
Mark Goldberg - CEO
John McIntyre - President
Chad Clark - President, Precision Value & Health
Scientific Founders:Ethan Leder, Mark Glickman
Board Members:Ethan Leder (Executive Chairman), Mark Glickman, Representatives from Blackstone and TPG
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Precision for Medicine. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.